Table 1 Demographics and clinical details of patients
2019 | 2021 | |||||||
|---|---|---|---|---|---|---|---|---|
Sensitive (336) | Resistant (112) | Adjusted odds ratio [CI] | p-value | Sensitive (201) | Resistant (116) | Adjusted odds ratio[CI] | p-value | |
Patients Age ≥ 60(%) | 146 (43.5) | 67 (59.8) | 1.64 [0.95, 2.82] | 0.07 | 112 (55.7) | 60 (52.2) | 0.67 [0.39, 1.17] | 0.16 |
Sex Male (%) | 170 (50.5) | 75 (66.9) | 1.82 [1.05, 3.14] | 0.03 | 110 (54.7) | 71 (61.2) | 0.99 [0.57, 1.72] | 0.98 |
Nationality International patients (%) | 52 (15.4) | 18 (16) | 2.20 [1.08, 4.48] | 0.03 | 12 (5.9) | 9 (7.8) | 1.71 [0.59, 4.97] | 0.32 |
Location IPD vs. OPD | 108 (32.1) | 25 (23) | 2.86 [1.31, 6.23] | 0.01 | 65 (32.3) | 22 (19.1) | 0.75 [0.35, 1.60] | 0.36 |
ICU vs. OPD | 31 (9.2) | 69 (61) | 24.38 [10.62, 55.98] | < 0.001 | 32 (15.9) | 66 (57.3) | 3.46 [1.64, 7.29] | < 0.001 |
Co-morbidities (%) | 117 (34.8) | 54 (48.2) | 1.11 [0.64, 1.92] | 0.72 | 96 (47.7) | 76 (65.5) | 2.88 [1.65, 5.02] | 0.00002 |
Length of stay Days 2–7 vs. Day 0–1 | 102 (30.4) | 34 (30.4) | 0.676 [0.304, 1.501] | 0.336 | 79 (39.3) | 37 (32.2) | 1.51 [0.7, 3.22] | 0.29 |
Days > 7 vs. Day 0–1 | 60 (17.9) | 55 (49.1) | 1.26 [0.563, 2.82] | 0.574 | 39 (19.4) | 59 (51.3) | 2.62 [1.13, 6.08] | 0.02 |
% Mortality | 5.4 | 18 | 2.36 [1.11, 5.01] | 0.03 | 5 | 26.1 | 3.08 [1.31, 7.26] | 0.01 |